Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) EBT Margin (2016 - 2026)

Cryo Cell International's EBT Margin history spans 17 years, with the latest figure at 0.92% for Q1 2026.

  • Quarterly results put EBT Margin at 0.92% for Q1 2026, down 578.0% from a year ago — trailing twelve months through Feb 2026 was 8.95% (down 1688.0% YoY), and the annual figure for FY2025 was 7.4%, down 1617.0%.
  • EBT Margin for Q1 2026 was 0.92% at Cryo Cell International, up from 59.06% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 18.3% in Q2 2024 to a low of 203.04% in Q4 2023.
  • The 5-year median for EBT Margin is 8.34% (2022), against an average of 7.03%.
  • The sharpest move saw EBT Margin crashed -21106bps in 2023, then surged 19254bps in 2024.
  • Year by year, EBT Margin stood at 8.02% in 2022, then plummeted by -2632bps to 203.04% in 2023, then skyrocketed by 95bps to 10.5% in 2024, then crashed by -463bps to 59.06% in 2025, then skyrocketed by 102bps to 0.92% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods came in at 0.92%, 59.06%, and 15.16% for Q1 2026, Q4 2025, and Q3 2025 respectively.